| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | | α2β1 Integrin Ligand Peptide TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 2259318-55-1 | DBCO-(PEG2-VC-PAB-MMAE)2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 1959551-27-9 | (R)-FT671 |
≥98% | | 询价 |
| 4 | | (R)-NVS-ZP7-4 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 2381196-81-0 | Boc-C1-PEG3-C4-OBn |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 103-26-4 | Methyl cinnamate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | | (Rac)-PF-06250112 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 92-35-3 | Thiochrome |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 20605-40-7 | Benzothiohydrazide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 75899-68-2 | 4-Hydroxynonenal |
≥98% | | 询价 |
| 11 | 2156655-68-2 | Autotaxin-IN-3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 2143452-20-2 | TSHR antagonist S37a |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 387867-13-2 | Tandutinib HCl(MLN518,CT53518) |
≥98% | | 询价 |
| 14 | | ERRαLigand-Linker Conjugates 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 808756-71-0 | ABT 102 |
≥98% | | 询价 |
| 16 | 1740-54-1 | Sebacamide |
≥98% | | 询价 |
| 17 | 1860819-82-4 | ATM-1001 |
≥98% | | 询价 |
| 18 | 910562-20-8 | Aganepag isopropyl |
≥98% | | 询价 |
| 19 | 34184-77-5 | Promegestone |
≥98% | | 询价 |
| 20 | 35575-96-3 | Azamethiphos |
≥98% | | 询价 |
| 21 | 62435-92-1 | RS 52367 |
≥98% | | 询价 |
| 22 | | CGP-57380 HCl |
≥98% | | 询价 |
| 23 | 201487-53-8 | BIM-46068 |
≥98% | | 询价 |
| 24 | 467-52-7 | Samandarone |
≥98% | | 询价 |
| 25 | 73713-68-5 | Benzoic acid,m-(1-phenylureido)- |
≥98% | | 询价 |
| 26 | 137-42-8 | Metam-sodium |
≥98% | | 询价 |
| 27 | 28953-25-5 | Sch 18099 |
≥98% | | 询价 |
| 28 | 201788-90-1 | Akt Inhibitor X |
≥98% | | 询价 |
| 29 | 303-98-0 | Ubidecarenone |
≥98% | | 询价 |
| 30 | 1774353-12-6 | 6bK |
≥98% | | 询价 |
| 31 | 4618-88-6 | Janus green |
≥98% | | 询价 |
| 32 | 6029-84-1 | Rinderine |
≥98% | | 询价 |
| 33 | 655-35-6 | Chromonar hydrochloride |
≥98% | | 询价 |
| 34 | 613-46-7 | 2-Naphthalenecarbonitrile |
≥98% | | 询价 |
| 35 | 335371-37-4 | AM-1714 |
≥98% | | 询价 |
| 36 | 1176235-08-7 | AkaLumine |
≥98% | | 询价 |
| 37 | 70529-66-7 | Acetylalanyltyrosine |
≥98% | | 询价 |
| 38 | 54-80-8 | Pronetalol |
≥98% | | 询价 |
| 39 | 1179330-52-9 | SPR741 HCl |
≥98% | | 询价 |
| 40 | 1179330-52-9 | SPR741 acetate |
≥98% | | 询价 |
| 41 | 841-67-8 | (S)-Thalidomide |
≥98% | | 询价 |
| 42 | 2614-06-4 | (R)-Thalidomide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 10030-85-0 | Rhamnose monohydrate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 53-05-4 | Tetrahydrocortisone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | | Neuromedin U,rat TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 126519-80-0 | OTs-C6-OBn |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 2098487-39-7 | Thalidomide-propargyl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 57530-40-2 | Ethacizine HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | | Galanin Receptor Ligand M35 TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | 1435779-45-5 | Prinomastat HCl |
≥98% | | 询价 |
| 51 | 155412-88-7 | CCK-B Receptor Antagonist 2 |
≥98% | | 询价 |
| 52 | | Fibronectin Adhesion-promoting Peptide TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 2056261-41-5 | BRD0705 HCl |
≥98% | | 询价 |
| 54 | 2281797-55-3 | mDPR(Boc)-Val-Cit-PAB |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 1383478-94-1 | CYM 9484 |
≥98% | | 询价 |
| 56 | | Angiotensin II(1-4),human TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 958772-66-2 | SID 26681509 |
≥98% | | 询价 |
| 58 | 158930-17-7 | Frovatriptan succinate hydrate |
≥98% | | 询价 |
| 59 | 96180-79-9 | Microcystin-LA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | 2376724-97-7 | Boc-C1-PEG3-C4-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com